Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...
Meet the winners of the inaugural IGNITE Awards—an elite group of campaigns setting a new standard for modern marketing. From breakthrough experiential activations and transformative retail strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results